News
Blocklisting Interim Review
18 December 2012
TyraTech, Inc. (AIM: TYR), a natural life sciences company, provides the following information in connection with its block admission pursuant to AIM Rule 29 and Schedule Six of the AIM Rules:
| Name of company: | TyraTech, Inc. |
| Name of scheme: | 2007 Equity Compensation Plan of the Company |
| Period of return: | From: 18 June 2012 To: 17 December 2012 |
| Number and class of securities not issued under the scheme | 5,146,246 common shares |
| Number of securities issued under the scheme during the period | Nil |
| Balance under the scheme of securities not yet issued at the end of the period | 5,146,246 common shares |
| Number and class of securities originally admitted and the date of admission | 5,183,746 common shares on 2 March 2011 |
| Name of contact: | Peter Jerome |
| Telephone number of contact: | +1 919 415 4280 |
For further information please contact:
TyraTech Inc.
Alan Reade, Executive Chairman
Tel: +1 919 415 4310
Peter Jerome, Chief Financial Officer
Tel: +1 919 415 4280
N+1 Singer, Nominated Adviser and Joint Broker
Aubrey Powell / Alex Wright
Tel: +44 20 3205 7500
First Columbus LLP, Joint Broker
Chris Crawford
Tel: +44 20 3002 2070
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.